ArriVent's lung cancer treatment fails late-stage trial
ArriVent's lung cancer treatment fails late-stage trial marketscreener.com
393 материалов по теме, собраны автоматически из проверенных источников
ArriVent's lung cancer treatment fails late-stage trial marketscreener.com
Chronic exposure to cigarette smoke may reprogram different populations of lung stem cells, which maintain and repair lung tissue, in ways that make them vulnerable to specific cancer-causing gene alterations and ultimately help determine the type of lung cancer that develops.
CAR-T cell therapies have fundamentally transformed the treatment of several blood and lymph node cancers. However, their use in solid tumors such as liver, breast or lung cancer has so far been significantly more difficult. This is due, among other things, to the lack of suitable target structures on the cancer…
Онколог объяснил почему обычная флюорография пропускает рак легких Главный Региональный
A new nanoparticle therapy reduced lung tumors in mice while also targeting cachexia, the severe muscle wasting that can accompany cancer. By delivering follistatin mRNA directly to tumors, the approach could eventually offer a way to fight both the disease and one of its most dangerous complications.
New clinical trial targeting immunotherapy resistance in lung cancer and melanoma treats first patient The Institute of Cancer Research (ICR)
Breath Test Spots Lung Cancer With Over 90% Accuracy in Landmark Trial Bioengineer.org
Кашель, который может указывать на рак легких - врач назвал симптом Cursorinfo
Кашель, который может указывать на рак легких - врач назвал симптом Cursorinfo
Abstract Submission for the European Lung Cancer Congress 2027 is Now Open – ESMO oncodaily.com
FDA Decision on Ifinatamab Deruxtecan for Small Cell Lung Cancer Expected by Oct. 10 Cure Today
Two Decades of Data Reveal How Small Molecule Drugs Reshaped Lung Cancer Treatment Bioengineer.org
Tarlatamab Shows Benefits in Small Cell Lung Cancer Brain Metastases Oncology News Central
A cancer drug will be tested in lung cancer; its prostate-cancer trial is enrolling. Stock Titan